Merck Technology Sample Clauses
The 'Merck Technology' clause defines what constitutes technology owned, developed, or controlled by Merck within the context of the agreement. It typically outlines the scope of intellectual property, know-how, patents, or proprietary information that Merck brings to the partnership or transaction. For example, it may specify that any inventions, software, or technical processes created by Merck prior to or during the collaboration are considered 'Merck Technology.' This clause is essential for clarifying ownership rights and ensuring that both parties understand which technologies are subject to licensing, use restrictions, or further development under the agreement.
Merck Technology. All right, title, and interest in and to Merck Technology shall, as between the Parties, be solely owned by Merck. Metabasis hereby assigns to Merck all right, title and interest it may have in any Merck Technology.
Merck Technology. MERCK has the sole responsibility to, at MERCK's discretion, file, conduct ex parte and inter partes prosecution, and maintain (including the defense of any interference or opposition proceedings) in the Territory, all Patent Rights comprising MERCK Technology (other than Joint Collaboration IP), in MERCK's name.
Merck Technology. On the terms and subject to the conditions of the Agreement, Merck hereby grants to Biosite an exclusive license (or in the case of licensed Third Party Patent Rights and Know-How, when permissible, an exclusive sublicense) under Merck's Patent Rights and Merck's Know-How, to perform its obligations under the Development Program, and to make, have made, use and sell the Product. Biosite may not grant sublicenses under such license to any Affiliate or Third Party without the prior written consent of Merck.
Merck Technology. In connection with the Collaboration, Merck may, but is not obligated to, make available to KalVista technology that is Controlled by Merck (the “Merck Technology”) in order to help advance the development of the Products under the Collaboration. If Merck notifies KalVista that it desires to make any Merck Technology available to KalVista, Merck shall grant and hereby grants to KalVista a worldwide, non-exclusive, non-sublicensable (except to KalVista’s contract research organizations or service providers that are providing services in connection with the Collaboration), royalty-free, fully paid license to use the Merck Technology to develop the Products under the Collaboration.